A new series by the Journal of Clinical Pathways offers insight from board members on the growth of clinical pathways.
Following are comments by some of the board members as part of the Ask the Board series:
“As the move from fee-for-service to value-based care continues to evolve, the role of evidence-based clinical pathways becomes ever more critical. The focus of value-based care is achieving and paying for consistent, best care. Clinical pathways are the tools that physicians and other clinicians use to address and reduce the variations in care that result in suboptimal and inconsistent outcomes and unnecessary use of resources.”
Lili Brillstein, MPH, chief executive officer, BCollaborative
“Over the past decade, mounting clinical evidence has shown that social determinants of health (SDOH)—defined by the World Health Organization as “the conditions in which people are born, grow, live, work and age”—are equally, if not more, important to driving health outcomes than a patient’s genes. These factors, which can include financial security, food security, social isolation, housing security, addiction, access to transportation and patient health literacy, impact all aspects of chronic, disabling, and life threatening disease management – from prevention to diagnosis and treatment to survivor care.”
Bruce A Feinberg, DO, vice president of clinical affairs and chief medical officer, Cardinal Health Specialty Solutions
To read the full article on JCP, click here.
